Hurley Capital LLC purchased a new position in shares of Danaher Co. (NYSE:DHR – Free Report) in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm purchased 142 shares of the conglomerate’s stock, valued at approximately $34,000.
Several other institutional investors have also added to or reduced their stakes in DHR. Heck Capital Advisors LLC bought a new stake in shares of Danaher in the fourth quarter valued at approximately $27,000. Decker Retirement Planning Inc. bought a new stake in shares of Danaher during the 4th quarter valued at $31,000. Golden State Wealth Management LLC bought a new position in shares of Danaher in the fourth quarter worth $31,000. Strategic Financial Concepts LLC acquired a new position in Danaher in the fourth quarter valued at about $31,000. Finally, Pineridge Advisors LLC grew its stake in Danaher by 63.3% during the fourth quarter. Pineridge Advisors LLC now owns 147 shares of the conglomerate’s stock worth $34,000 after buying an additional 57 shares in the last quarter. 79.05% of the stock is currently owned by institutional investors.
Analyst Ratings Changes
DHR has been the topic of several analyst reports. JPMorgan Chase & Co. reduced their price target on shares of Danaher from $310.00 to $300.00 and set an “overweight” rating on the stock in a research report on Tuesday, January 28th. Barclays reduced their target price on Danaher from $275.00 to $240.00 and set an “equal weight” rating on the stock in a report on Thursday, January 30th. Guggenheim assumed coverage on Danaher in a research report on Thursday, December 19th. They set a “buy” rating and a $275.00 price objective for the company. Raymond James reiterated a “market perform” rating on shares of Danaher in a research report on Monday, February 3rd. Finally, Citigroup dropped their target price on shares of Danaher from $285.00 to $265.00 and set a “buy” rating for the company in a report on Thursday, January 30th. Five equities research analysts have rated the stock with a hold rating and seventeen have assigned a buy rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $278.24.
Insider Transactions at Danaher
In other news, SVP Brian W. Ellis sold 5,700 shares of the company’s stock in a transaction that occurred on Thursday, January 30th. The stock was sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the transaction, the senior vice president now directly owns 20,230 shares of the company’s stock, valued at $4,534,149.90. This represents a 21.98 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Insiders own 11.10% of the company’s stock.
Danaher Price Performance
Shares of DHR opened at $181.42 on Friday. The business has a 50-day moving average of $209.99 and a 200-day moving average of $233.99. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.40 and a quick ratio of 1.05. The company has a market capitalization of $129.66 billion, a price-to-earnings ratio of 34.36, a price-to-earnings-growth ratio of 2.66 and a beta of 0.86. Danaher Co. has a 1 year low of $181.20 and a 1 year high of $281.70.
Danaher (NYSE:DHR – Get Free Report) last posted its quarterly earnings data on Wednesday, January 29th. The conglomerate reported $2.14 EPS for the quarter, meeting analysts’ consensus estimates of $2.14. Danaher had a net margin of 16.33% and a return on equity of 10.82%. During the same period last year, the company posted $2.09 EPS. As a group, equities research analysts anticipate that Danaher Co. will post 7.63 earnings per share for the current year.
Danaher Increases Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Friday, March 28th will be issued a dividend of $0.32 per share. The ex-dividend date of this dividend is Friday, March 28th. This represents a $1.28 annualized dividend and a dividend yield of 0.71%. This is a positive change from Danaher’s previous quarterly dividend of $0.27. Danaher’s dividend payout ratio is currently 24.24%.
Danaher Profile
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Featured Articles
- Five stocks we like better than Danaher
- Following Congress Stock Trades
- Conagra Stock Could Thrive as Tariffs Hit Other Sectors
- How to Most Effectively Use the MarketBeat Earnings Screener
- Grocery Costs and Tariffs Now Top of Mind in Everyday Conversations, New Survey Finds
- Canada Bond Market Holiday: How to Invest and Trade
- Spotify Stock Eyes Double-Digit UpsideāIs Now the Time to Buy?
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.